BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/7/2017 8:24:12 AM | Browse: 281 | Download: 350
Publication Name World Journal of Clinical Oncology
Manuscript ID 28882
Country of Manuscript Source France
Received
2016-07-20 14:37
Peer-Review Started
2016-07-21 14:18
To Make the First Decision
2016-09-05 09:13
Return for Revision
2016-09-05 17:11
Revised
2016-09-16 22:39
Second Decision
2016-09-28 11:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-10-18 16:36
Articles in Press
2016-10-18 16:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-03-30 14:42
Publish the Manuscript Online
2017-04-07 08:24
ISSN 2218-4333 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Oncology
Manuscript type Review
Article Title Targeted therapies in breast cancer: New challenges to fight against resistance
Manuscript Source Unsolicited Manuscript
All Author List Viviana Masoud and Gilles Pagès
Funding Agency and Grant Number
Funding Agency Grant Number
French Association for Cancer Research (ARC)
Fondation de France
French National Institute for Cancer Research (INCA)
Fondation Estée Lauder (Pink Ribbon Award)
Roche France and “Cordon de Vie” Monaco
Correspondence To Gilles Pagès, PhD, Director of Research INSERM, University Nice Sophia Antipolis, Institute for Research on Cancer and Aging of Nice CNRS UMR7284/INSERM U 1081, Centre Antoine Lacassagne 33 Avenue de Valombrose, 06189 Nice, France. gpages@unice.fr
Keywords Breast cancers; Resistance; Human epidermal growth factor receptor 2; Angiogenesis; Triple negative; Immune tolerance
Core Tip There are several reviews in the literature dedicated to breasts cancers. However, our manuscript is an updated review on the current knowledge and particularly on the molecular mechanisms involved in the relapse of patients on the current treatments. A summary of ongoing clinical trials gives a perspective for future therapeutic strategies. Our manuscript represents a working document for researchers/oncologists in the field of breast cancers.
Publish Date 2017-04-07 08:24
Citation Masoud V, Pagès G. Targeted therapies in breast cancer: New challenges to fight against resistance. World J Clin Oncol 2017; 8(2): 120-134
Url http://www.wjgnet.com/2218-4333/full/v8/i2/120.htm
DOI http://dx.doi.org/10.5306/wjco.v8.i2.120
Full Article (PDF) WJCO-8-120.pdf
Full Article (Word) WJCO-8-120.doc
Manuscript File 28882-Review.docx
Answering Reviewers 28882-Answering reviewers.pdf
Audio Core Tip 28882-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 28882-Conflict-of-interest statement.pdf
Copyright License Agreement 28882-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 28882-Grant application form(s).pdf
Peer-review Report 28882-Peer-review(s).pdf
Scientific Misconduct Check 28882-Scientific misconduct check.pdf
Scientific Editor Work List 28882-Scientific editor work list.pdf